Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
Tóm tắt
Từ khóa
Tài liệu tham khảo
1997, A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project., Blood, 89, 3909, 10.1182/blood.V89.11.3909
Horning, 1984, The natural history of initially untreated low-grade non-Hodgkin’s lymphomas., N Engl J Med, 311, 1471, 10.1056/NEJM198412063112303
Acker, 1983, Histologic conversion in the non-Hodgkin’s lymphomas., J Clin Oncol, 1, 11, 10.1200/JCO.1983.1.1.11
Garvin, 1983, An autopsy study of histologic progression in non-Hodgkin’s lymphomas. 192 cases from the National Cancer Institute., Cancer, 52, 393, 10.1002/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M
Montoto, 2011, Transformation of indolent B-cell lymphomas., J Clin Oncol, 29, 1827, 10.1200/JCO.2010.32.7577
Tan
Horning, 1993, Natural history of and therapy for the indolent non-Hodgkin’s lymphomas., Semin Oncol, 20, 75
Fisher, 2005, New treatment options have changed the survival of patients with follicular lymphoma., J Clin Oncol, 23, 8447, 10.1200/JCO.2005.03.1674
Swenson, 2005, Improved survival of follicular lymphoma patients in the United States., J Clin Oncol, 23, 5019, 10.1200/JCO.2005.04.503
Liu, 2006, Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center., J Clin Oncol, 24, 1582, 10.1200/JCO.2005.03.3696
Marcus, 2005, CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma., Blood, 105, 1417, 10.1182/blood-2004-08-3175
Hiddemann, 2005, Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group., Blood, 106, 3725, 10.1182/blood-2005-01-0016
Salles, 2007, Final Analysis of the GELA-GOELAMS FL2000 Study with a 5-Year Follow-Up., Blood, 110
Herold, 2007, Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study., J Clin Oncol, 25, 1986, 10.1200/JCO.2006.06.4618
Marcus, 2008, Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma., J Clin Oncol, 26, 4579, 10.1200/JCO.2007.13.5376
Hochster, 2009, Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study., J Clin Oncol, 27, 1607, 10.1200/JCO.2008.17.1561
Jaffe
Brice, 1997, Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. Groupe d’Etude des Lymphomes de l’Adulte., J Clin Oncol, 15, 1110, 10.1200/JCO.1997.15.3.1110
Solal-Céligny, 2004, Follicular lymphoma international prognostic index., Blood, 104, 1258, 10.1182/blood-2003-12-4434
Kaplan, 1958, Nonparametric estimation from incomplete observations., Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452
Peto, 1973, Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data., Biometrics, 29, 579, 10.2307/2529177
Human Mortality Database University of California, Berkeley (USA) and Max Planck Institute for Demographic Research (Germany) Available at: http://www.mortality.org or http://www.humanmortality.de Accessed October 16, 2011
Ederer, 1961, The relative survival rate: a statistical methodology., Natl Cancer Inst Monogr, 6, 101
Voutilainen, 1998, SURV2: Relative Survival Analysis Program, version 3. Vol Version 3
Friedberg, 2009, Follicular lymphoma in the United States: first report of the national LymphoCare study., J Clin Oncol, 27, 1202, 10.1200/JCO.2008.18.1495
Solal-Céligny, 1996, Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d’Etude des Lymphomes de l’Adulte., J Clin Oncol, 14, 514, 10.1200/JCO.1996.14.2.514
McLaughlin, 1996, Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma., J Clin Oncol, 14, 1262, 10.1200/JCO.1996.14.4.1262
Velasquez, 2003, Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501., J Clin Oncol, 21, 1996, 10.1200/JCO.2003.09.047
Hsu, 1997, Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma—long-term results of a clinical trial., Blood, 89, 3129, 10.1182/blood.V89.9.3129
Conconi, 2010, Patterns of survival of follicular lymphomas at a single institution through three decades., Leuk Lymphoma, 51, 1028, 10.3109/10428191003743460
Salles, 2008, Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study., Blood, 112, 4824, 10.1182/blood-2008-04-153189
Bachy, 2010, Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival—A study from the groupe d’etude des lymphomes de l’adulte., J Clin Oncol, 28, 822, 10.1200/JCO.2009.22.7819
Schulz, 2007, Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis., J Natl Cancer Inst, 99, 706, 10.1093/jnci/djk152
Sacchi, 2007, Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients., Cancer, 109, 2077, 10.1002/cncr.22649
Federico, 2000, Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi., Blood, 95, 783
Hasselblom, 2007, The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study., Leuk Lymphoma, 48, 736, 10.1080/10428190601187703